For sarcoma cell lines the abrogation of p53-induced apoptosis by blocking NF-κB is described as a mechanism of drug resistance [25,26], whereas HT-1080 cells acquire chemoresistance through the activation of NF-κB to mediate cell survival [18]. Here, TP53 is linked to sarcoma.